Delivery Order SPE2DB20D3103-SPE2DB23FP4H3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pylera Capsule pharmaceutical products, with a ceiling value of $6,341.38 and a completion date of February 24, 2022. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,141.56, is for the delivery of Pylera Capsules and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- This delivery order, awarded November 20, 2025, procures Pylera Capsules (120-count units) for the Defense Logistics Agency, with a ceiling value of $4,859.58 and completion deadline of November 21, 2025. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, under firm fixed-price terms with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,625.39 firm fixed-price delivery order contract is for the supply of Pylera Capsules, with a performance period through December 20, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and both companies are registered in the System for Award Management (SAM) as for-profit organizations. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is valued at $2,039.76 for the delivery of Pylera Capsules. The contract has a firm fixed price and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical...
- This federal contract award, valued at $17,924.52, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under the existing Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the delivery of pharmaceutical products, including PYLERA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,323.67 delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which runs through November 2026 and serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,819.31 for the supply of 4558206944 PYLERA CAPSULE UU 120S. The contract has an ultimate completion date of August 25, 2022 and is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Pylera Capsule UU 120s, a combination antibiotic medication used to treat Helicobacter pylori infections. The contract is valued at $2,266.10 under a firm fixed-price arrangement, with an ultimate completion date of April 25, 2025. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Firm Fixed Price Delivery Order valued at $2,141.88 and issued by the Defense Logistics Agency (DLA). The contract is for the supply of PYLERA CAPSULE UU 120S and has an ultimate completion date of January 31, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP4H3Delivery Order
This federal contract award is for the delivery of Pylera capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,848.80 and a period of performance through August 22, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. The contract award does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/21/23 |